Catch Demeetra at PEGS Boston 2025
May 12–16, 2025
Hynes Convention Center | Boston, MA
We’re bringing our latest innovations in gene editing and cell line engineering to PEGS Boston 2025—and we’d love to connect.
Stop by Booth #806 to meet our Business Development Managers, Koy Saephan and Christian Cummings, and learn how Demeetra is pushing the boundaries of genome editing. Whether you're working on difficult-to-express proteins, cell line development, or looking for a more precise, easier to license alternative to CRISPR/Cas9, our team is ready to dive in.
We’re also proud to highlight a featured talk from Dr. Corey Brizzee, PhD, who will be presenting in the C5A: Difficult-to-Express Proteins track.
Presentation Details
- Title: Enhancing Genome Editing Capabilities: Unveiling the Advantages of Cas-CLOVER over CRISPR/Cas9
- When: Tuesday, May 13, 2025 | 8:50 AM
Dr. Brizzee will showcase how Cas-CLOVER, our proprietary targeted nuclease, outperforms traditional CRISPR/Cas9 in targeted integration efficiency—key for enabling stable and high expression in even the most challenging expression systems.
PEGS is where protein engineering meets innovation—come see how Demeetra is contributing to the future of biologics.